Treating hepatitis C virus in patients with decompensated cirrhosis: Why is it so difficult and does a sustained response rate rescue the patient from liver transplantation?-Reference-Cited by-同舟云学术

Treating hepatitis C virus in patients with decompensated cirrhosis: Why is it so difficult and does a sustained response rate rescue the patient from liver transplantation?

Published:2015-12 Issue:6 Volume:6 Page:133-135
ISSN:2046-2484
Container-title:Clinical Liver Disease
language:en
Short-container-title:Clinical Liver Disease

Author:

Kwo Paul¹,Agrawal Saurabh¹²

Affiliation:

1. Department of Medicine; Indiana University School of Medicine; Indianapolis IN 46202

2. Purdue University; West Lafayette IN

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.519/fullpdf

Reference14 articles.

1. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival;Shiratori;Ann Intern Med,2005

2. Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis: a retrospective study;Bruno;Hepatology,2007

3. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis;Meer;JAMA,2012

4. The association between hepatitis C infection and survival after orthotopic liver transplantation;Forman;Gastroenterology,2002

5. Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease;Charlton;Gastroenterology,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HCV Treatment in Decompensated Disease;Current Hepatology Reports;2022-06

2. Hepatitis C;Gastroenterology Clinics of North America;2020-06

3. Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?;Hepatology International;2019-02-13

4. Hepatitis C and liver transplantation;Minerva Gastroenterology;2018-03

5. Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort study;Journal of Viral Hepatitis;2017-02-20